journal article·2014-11

Synthesis and characterization of chlorhexidine acetate drug–montmorillonite intercalates for antibacterial applications

Kasturi Saha, B.S. Butola, Mangala Joshi

Publisher page

Abstract

Abstract In this study, a drug intercalated montmorillonite (Mt) has been prepared which can be useful in designing novel topical drug delivery system. The drug–Mt intercalates were synthesized by ion exchange route where interlayer cations i.e., K + , Na + etc. of Na + –Mt exchange with the cation of the drug, chlorhexidine acetate (Ca ++ ). The characterization of drug–Mt intercalates has been done using X-ray diffraction, Fourier transform infrared spectroscopy, thermogravimetric technique and energy dispersive X-ray analysis; all of which indicate successful intercalation of drug into the interlayer space. These drug–Mt intercalates strongly inhibited the growth of a wide range of microorganisms including both Staphylococcus aureus and Escherichia coli . In vitro release study of the antibacterial drug–Mt intercalates in phosphate buffer saline (pH 7.4) media at 37 °C was investigated. The pattern was found to be initially burst release followed by sustained release. The Ca ++ –Mt intercalates with a wide range of bioactivity against microbes and controlled release characteristics have the potential for application in the area of topical drug delivery.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Clay minerals and soil interactions · Therapeutic Uses of Natural Elements · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (23)

Show source-provided references
1. High strength–toughness combination of melt intercalated nanoclay reinforced thermoplastic olefins10.1016/j.msea.2007.01.045 ↗
2. Types of antimicrobial agents
3. Hybrid materials based on montmorillonite and citostatic drugs: preparation and characterization10.1016/j.clay.2011.01.031 ↗
4. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole10.1016/j.ijpharm.2007.08.008 ↗
5. Intercalation of amido cationic drug with montmorillonite10.1007/s11595-005-2250-4 ↗
6. Montmorillonite–thermoset nanocomposites via cryo-compounding10.1016/j.polymer.2006.03.057 ↗
7. The mechanism of action of chlorhexidine10.1111/j.1574-6968.1992.tb05705.x ↗
8. Clay mineral–organic interactions
9. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier10.1016/S0142-9612(01)00325-8 ↗
10. In vitro adsorption of various pharmaceuticals to montmorillonite10.1002/jps.2600650623 ↗
11. Controlled release and antibacterial activity chlorhexidine acetate (CA) intercalated in montmorillonite10.1016/j.ijpharm.2009.08.004 ↗
12. Instrumental characterization of clay by XRF, XRD and FTIR10.1007/s12034-007-0042-5 ↗
13. Structural model calculation of antimicrobial and antifungal agents derived from clay minerals10.1016/S0169-1317(98)00008-8 ↗
14. Chlorhexidine: antibacterial action and bacterial resistance10.1007/BF01644264 ↗
15. Clay–polymer nanocomposites as a novel drug carrier: synthesis, characterization and controlled release study of propranolol hydrochloride10.1016/j.clay.2013.06.009 ↗
16. Van Olphen · 1963
17. Some physicochemical properties of the montmorillonites10.1002/jps.2600551110 ↗
18. Antimicrobial preservatives used by the cosmetic industry
19. Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity
20. Structure of organoclays—an X-ray diffraction and thermogravimetric analysis study10.1016/j.jcis.2004.04.053 ↗
21. Thermal characterization of organically modified montmorillonite10.1016/S0040-6031(00)00690-0 ↗
22. Nanoscale near surface deformation in polymer nanocomposites10.1016/j.actamat.2007.12.051 ↗
23. Study on ibuprofen/montmorillonite intercalation composites as drug release system10.1016/j.clay.2007.01.012 ↗